Skip to main content

Find Clinical Trials

Home
Conditions
Postmenopausal Osteoporosis

Clinical trial condition

Postmenopausal Osteoporosis

Explore clinical trials studying Postmenopausal Osteoporosis. Study availability and eligibility vary by location and protocol.

95 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Postmenopausal Osteoporosis trial results

Completed

PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia

NCT02598453

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations: Montgomery, Alabama, United States

Lake Havasu City, Arizona, United States

Paradise Valley, Arizona, United States

Pine Bluff, Arkansas, United States

View all 60 locations

View Trial Details

Completed

BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis

NCT00545909

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations: Bregenz, Austria

Graz, Austria

Innsbruck, Austria

Linz, Austria

View all 57 locations

View Trial Details

Completed

A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)

NCT00545363

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations: Békéscsaba, Hungary

Budapest, Hungary

Budapest, Hungary

Budapest, Hungary

View all 52 locations

View Trial Details

Completed

A Study to Determine the Patient Preference Between Zosano Pharma Parathyroid Hormone (ZP-PTH) Patch and Forteo Pen

NCT02478879

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations: Covance Daytona Beach Clinical Research Unit Daytona Beach, Florida, United States

View Trial Details

Completed

A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.

NCT00545051

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations: Hämeenlinna, Finland

Helsinki, Finland

Helsinki, Finland

Helsinki, Finland

View all 15 locations

View Trial Details

Completed

Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women

NCT00578981

Conditions: Bone Diseases, Bone Diseases, Metabolic, Bone Loss, Age Related, +7 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)

NCT00996801

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women

NCT00918749

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations: Research Site Daytona Beach, Florida, United States

Research Site Fort Myers, Florida, United States

Research Site Honolulu, Hawaii, United States

Research Site Evansville, Indiana, United States

View Trial Details

Completed

Epidemiology, Identification Rate and Treatment Penetration of Osteoporotic Vertebral Fractures in Switzerland

NCT02234414

Conditions: Back Injuries, Bone Diseases, Bone Diseases, Metabolic, +10 more
Locations: Kantonsspital Olten Olten, Switzerland

HFR Tafers Tafers, Switzerland

Hochgebirgsklinik Davos Wolfgang, Switzerland

View Trial Details

Completed

A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density

NCT00293813

Conditions: Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations: Not specified

View Trial Details